Company intelligence / Profile preview

Apixio

San Mateo, California, USA

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Apixio does not have drug clinical results; it provides advanced AI and machine learning platforms to analyze healthcare data, support risk adjustment, payment integrity, and quality measurement in health plans and care delivery, driving improved patient insights and value-based care.[1][2][5][6]

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Blue Cross Blue Shield (Medicare Advantage partnerships with 46% of BCBS companies)[2]

Beyond the preview

Go deeper on Apixio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apixio.

Explore the full profile